search
Back to results

Non-surgical Treatment of Peri-implant Mucositis: FMUD vs FMUD and Air-Flow Master Piezon®

Primary Purpose

Peri-implant Mucositis

Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Glycine powder air polishing
Full mouth ultrasonic debridement
Sponsored by
University of Siena
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Peri-implant Mucositis focused on measuring Peri-implant Mucosits, air polishing device, non-surgical treatment

Eligibility Criteria

18 Years - 70 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: age between 18 and 70 years old; presence of one implant loaded at least one year before; bleeding on probing and/or suppuration of the peri-implant mucosa; pain and/or tenderness of the peri-implant mucosa; good general health conditions. Exclusion Criteria: radiographic bone loss ≥ 2mm; intake of anticoagulants, antiplatelet, antibiotic or cortisone drugs; inability to perform oral hygiene maneuvers.

Sites / Locations

  • AOUS

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Full mouth ultrasonic debridement plus glycine powder air polishing

Full mouth ultrasonic debridement

Arm Description

Plaque and calculus are firstly removed through full mouth ultrasonic debridement (FMUD) in all sites (both dental and implant). After this procedure an air polishing device (Air-flow Master Piezon®) is used as additional therapy to further debride peri-implant trans-mucosal tract.

Plaque and calculus are removed through full mouth ultrasonic debridement (FMUD) in all sites (both dental and implant).

Outcomes

Primary Outcome Measures

Bleeding on probing
After probing dental and implant sites a dichotomic value (0/1) is assigned for each site. 0: not bleeding site; 1: bleeding site.

Secondary Outcome Measures

Probing pocket depth change
Change in probing pocket depth measured in millimeter through a periodontal probe.

Full Information

First Posted
March 4, 2020
Last Updated
July 25, 2023
Sponsor
University of Siena
search

1. Study Identification

Unique Protocol Identification Number
NCT05801315
Brief Title
Non-surgical Treatment of Peri-implant Mucositis: FMUD vs FMUD and Air-Flow Master Piezon®
Official Title
Treatment of Peri-implant Mucositis: Adjunctive Benefit of Glycine Powder Air Polishing Device to Professional Mechanical Biofilm Removal. A Randomized Parallel Arm Clinical Study
Study Type
Interventional

2. Study Status

Record Verification Date
July 2023
Overall Recruitment Status
Completed
Study Start Date
March 1, 2020 (Actual)
Primary Completion Date
March 20, 2023 (Actual)
Study Completion Date
March 20, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Siena

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The aim of the present study is to evaluate the adjunctive effect of glycine-powder air-polishing (GPAP) to full-mouth ultrasonic debridement (Fm-UD) in the treatment of peri-implant mucositis, and to determine the predictive role of implant and patient-level variables for disease resolution. Both treatments are described in the literature, but few studies are available on their comparison.
Detailed Description
52 patients (132 implants) with peri-implant mucositis were included in this randomized parallel arm clinical study. Following baseline variables assessment, participants received Fm-UD. Implants allocated to the test group (n=64) were additionally treated with GPAP. Clinical outcomes were evaluated at 3 and 12 months following intervention. Complete and partial disease resolution were defined as absence of BoP (DR1) or <2 BoP+ sites (DR2), respectively.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Peri-implant Mucositis
Keywords
Peri-implant Mucosits, air polishing device, non-surgical treatment

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
52 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Full mouth ultrasonic debridement plus glycine powder air polishing
Arm Type
Experimental
Arm Description
Plaque and calculus are firstly removed through full mouth ultrasonic debridement (FMUD) in all sites (both dental and implant). After this procedure an air polishing device (Air-flow Master Piezon®) is used as additional therapy to further debride peri-implant trans-mucosal tract.
Arm Title
Full mouth ultrasonic debridement
Arm Type
Active Comparator
Arm Description
Plaque and calculus are removed through full mouth ultrasonic debridement (FMUD) in all sites (both dental and implant).
Intervention Type
Device
Intervention Name(s)
Glycine powder air polishing
Intervention Description
Peri-implant mucositis sites treated with a glycine powder air polishing device (Air-Flow Master Piezon®).
Intervention Type
Device
Intervention Name(s)
Full mouth ultrasonic debridement
Intervention Description
Peri-implant mucositis sites are treated with thin ultrasonic tips.
Primary Outcome Measure Information:
Title
Bleeding on probing
Description
After probing dental and implant sites a dichotomic value (0/1) is assigned for each site. 0: not bleeding site; 1: bleeding site.
Time Frame
12 months
Secondary Outcome Measure Information:
Title
Probing pocket depth change
Description
Change in probing pocket depth measured in millimeter through a periodontal probe.
Time Frame
12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: age between 18 and 70 years old; presence of one implant loaded at least one year before; bleeding on probing and/or suppuration of the peri-implant mucosa; pain and/or tenderness of the peri-implant mucosa; good general health conditions. Exclusion Criteria: radiographic bone loss ≥ 2mm; intake of anticoagulants, antiplatelet, antibiotic or cortisone drugs; inability to perform oral hygiene maneuvers.
Facility Information:
Facility Name
AOUS
City
Siena
ZIP/Postal Code
53100
Country
Italy

12. IPD Sharing Statement

Learn more about this trial

Non-surgical Treatment of Peri-implant Mucositis: FMUD vs FMUD and Air-Flow Master Piezon®

We'll reach out to this number within 24 hrs